Unaudited Condensed Consolidated Statements of Changes in Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands | Total | Series B-1 | Series B-2 | Previously Reported | Revision of Prior Period, Adjustment | Common Stock | Common Stock Previously Reported | Common Stock Revision of Prior Period, Adjustment | Additional Paid-In Capital | Additional Paid-In Capital Previously Reported | Additional Paid-In Capital Revision of Prior Period, Adjustment | Accumulated Deficit | Accumulated Deficit Previously Reported | Accumulated Deficit Revision of Prior Period, Adjustment | Accumulated Other Comprehensive Loss | Noncontrolling Interest |
Beginning balance (in shares) at Dec. 31, 2020 | | 15,717,345 | | | 33,366,839 | 49,084,184 | | | | | | | | | | | | | | |
Beginning balance at Dec. 31, 2020 | | $ 156,848 | | | | $ 156,848 | | | | | | | | | | | | | | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Issuance of Series B-1 and B-2 convertible preferred stock upon conversion of convertible notes and accrued interest (in shares) | | | 27,947 | | | | | | | | | | | | | | | | | |
Issuance of Series B-1 and B-2 Convertible preferred stock upon conversion of convertible notes and accrued interest | | | $ 111 | | | | | | | | | | | | | | | | | |
Ending balance (in shares) at Mar. 31, 2021 | | 49,112,131 | | | | | | | | | | | | | | | | | | |
Ending balance at Mar. 31, 2021 | | $ 156,959 | | | | | | | | | | | | | | | | | | |
Beginning balance (in shares) at Dec. 31, 2020 | | | | | | | 22,773,377 | | 48,346,309 | | 71,119,686 | | | | | | | | | |
Beginning balance at Dec. 31, 2020 | | (7,499) | | | | $ (7,499) | | [1] | | [1] | | $ 52,561 | | $ 52,561 | $ (60,060) | | $ (60,060) | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Issuance of Class AA common stock upon exercise of vested stock options, including stock options exercised via promissory notes (in shares) | | | | | | | 473,658 | | | | | | | | | | | | | |
Issuance of Class AA common stock upon exercise of vested stock options, including stock options exercised via promissory notes | | 168 | | | | | | [1] | | | | 168 | | | | | | | | |
Issuance of Class AA common stock upon early exercise of unvested stock options (in shares) | | | | | | | 1,672,270 | | | | | | | | | | | | | |
Vesting of early exercised stock options and restricted stock awards | | 11 | | | | | | | | | | 11 | | | | | | | | |
Share-based compensation expense | | 1,259 | | | | | | | | | | 1,259 | | | | | | | | |
Net income (loss) | | 938 | | | | | | | | | | | | | 938 | | | | | |
Ending balance (in shares) at Mar. 31, 2021 | | | | | | | 73,265,614 | | | | | | | | | | | | | |
Ending balance at Mar. 31, 2021 | | $ (5,123) | | | | | | [1] | | | | 53,999 | | | (59,122) | | | $ 0 | $ 0 | |
Beginning balance (in shares) at Dec. 31, 2020 | | 15,717,345 | | | 33,366,839 | 49,084,184 | | | | | | | | | | | | | | |
Beginning balance at Dec. 31, 2020 | | $ 156,848 | | | | $ 156,848 | | | | | | | | | | | | | | |
Ending balance (in shares) at Sep. 30, 2021 | | 73,914,148 | | | | | | | | | | | | | | | | | | |
Ending balance at Sep. 30, 2021 | | $ 246,056 | | | | | | | | | | | | | | | | | | |
Beginning balance (in shares) at Dec. 31, 2020 | | | | | | | 22,773,377 | | 48,346,309 | | 71,119,686 | | | | | | | | | |
Beginning balance at Dec. 31, 2020 | | (7,499) | | | | $ (7,499) | | [1] | | [1] | | 52,561 | | 52,561 | (60,060) | | (60,060) | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Net income (loss) | | (12,139) | | | | | | | | | | | | | | | | | | |
Foreign currency translation adjustment | | 0 | | | | | | | | | | | | | | | | | | |
Ending balance (in shares) at Sep. 30, 2021 | | | | | | | 63,001,701 | | | | | | | | | | | | | |
Ending balance at Sep. 30, 2021 | | $ (48,705) | | | | | | [1] | | | | 23,494 | | | (72,199) | | | 0 | 0 | |
Beginning balance (in shares) at Dec. 31, 2020 | | 15,717,345 | | | 33,366,839 | 49,084,184 | | | | | | | | | | | | | | |
Beginning balance at Dec. 31, 2020 | | $ 156,848 | | | | $ 156,848 | | | | | | | | | | | | | | |
Ending balance (in shares) at Dec. 31, 2021 | | 73,914,149 | 42,133,496 | 412,623 | 23,668,198 | 50,245,951 | | | | | | | | | | | | | | |
Ending balance at Dec. 31, 2021 | | $ 246,056 | $ 150,553 | $ 1,640 | $ 246,056 | | | | | | | | | | | | | | | |
Beginning balance (in shares) at Dec. 31, 2020 | | | | | | | 22,773,377 | | 48,346,309 | | 71,119,686 | | | | | | | | | |
Beginning balance at Dec. 31, 2020 | | (7,499) | | | | $ (7,499) | | [1] | | [1] | | 52,561 | | 52,561 | (60,060) | | $ (60,060) | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Unissued common stock (in shares) | [2] | | | | | | | | | | (210,302) | | | | | | | | | |
Pre-close issuance of common stock upon exercise of vested options | [1] | | | | | | | | | | | | | | | | | | | |
Pre-close issuance of common stock upon exercise of unvested options | [1] | | | | | | | | | | | | | | | | | | | |
Pre-close issuance of common stock for services | [1] | | | | | | | | | | | | | | | | | | | |
Ending balance (in shares) at Dec. 31, 2021 | | | | | | | 63,090,701 | | 20,269,864 | | 43,031,139 | | | | | | | | | |
Ending balance at Dec. 31, 2021 | | $ (52,640) | | | $ (52,640) | | $ 5 | | | [1] | $ 5 | 25,914 | $ 25,919 | (5) | (78,559) | $ (78,559) | | | | |
Beginning balance (in shares) at Mar. 31, 2021 | | 49,112,131 | | | | | | | | | | | | | | | | | | |
Beginning balance at Mar. 31, 2021 | | $ 156,959 | | | | | | | | | | | | | | | | | | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Issuance of Series B-1 and B-2 convertible preferred stock upon conversion of convertible notes and accrued interest (in shares) | | | 12,719,398 | 412,623 | | | | | | | | | | | | | | | | |
Issuance of Series B-1 and B-2 Convertible preferred stock upon conversion of convertible notes and accrued interest | | | $ 47,735 | $ 1,640 | | | | | | | | | | | | | | | | |
Exchange of Class AA common stock for Series B-1 convertible preferred stock (in shares) | | 11,669,996 | | | | | | | | | | | | | | | | | | |
Exchange of Class AA common stock for Series B-1 convertible preferred stock | | $ 39,722 | | | | | | | | | | | | | | | | | | |
Ending balance (in shares) at Jun. 30, 2021 | | 73,914,148 | | | | | | | | | | | | | | | | | | |
Ending balance at Jun. 30, 2021 | | $ 246,056 | | | | | | | | | | | | | | | | | | |
Beginning balance (in shares) at Mar. 31, 2021 | | | | | | | 73,265,614 | | | | | | | | | | | | | |
Beginning balance at Mar. 31, 2021 | | (5,123) | | | | | | [1] | | | | 53,999 | | | (59,122) | | | 0 | 0 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Exchange and settlement of common stock | | (39,722) | | | | | | [1] | | | | (39,722) | | | | | | | | |
Issuance of Class AA common stock upon exercise of vested stock options, including stock options exercised via promissory notes (in shares) | | | | | | | 376,328 | | | | | | | | | | | | | |
Issuance of Class AA common stock upon exercise of vested stock options, including stock options exercised via promissory notes | | 322 | | | | | | [1] | | | | 322 | | | | | | | | |
Issuance of Class AA common stock upon early exercise of unvested stock options (in shares) | | | | | | | 701,878 | | | | | | | | | | | | | |
Repurchase of early exercised stock options (in shares) | | | | | | | (12,291) | | | | | | | | | | | | | |
Exchange of Class AA common stock for Series B-1 convertible preferred stock (in shares) | | | | | | | (11,669,996) | | | | | | | | | | | | | |
Vesting of early exercised stock options and restricted stock awards | | 45 | | | | | | | | | | 45 | | | | | | | | |
Share-based compensation expense | | 5,892 | | | | | | | | | | 5,892 | | | | | | | | |
Net income (loss) | | (8,003) | | | | | | | | | | | | | (8,003) | | | | | |
Ending balance (in shares) at Jun. 30, 2021 | | | | | | | 62,661,533 | | | | | | | | | | | | | |
Ending balance at Jun. 30, 2021 | | $ (46,589) | | | | | | [1] | | | | 20,536 | | | (67,125) | | | 0 | 0 | |
Ending balance (in shares) at Sep. 30, 2021 | | 73,914,148 | | | | | | | | | | | | | | | | | | |
Ending balance at Sep. 30, 2021 | | $ 246,056 | | | | | | | | | | | | | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Issuance of Class AA common stock upon exercise of vested stock options, including stock options exercised via promissory notes (in shares) | | | | | | | 191,313 | | | | | | | | | | | | | |
Issuance of Class AA common stock upon exercise of vested stock options, including stock options exercised via promissory notes | | 87 | | | | | | [1] | | | | 87 | | | | | | | | |
Issuance of Class AA common stock upon early exercise of unvested stock options (in shares) | | | | | | | 166,424 | | | | | | | | | | | | | |
Repurchase of early exercised stock options (in shares) | | | | | | | (17,569) | | | | | | | | | | | | | |
Vesting of early exercised stock options and restricted stock awards | | 46 | | | | | | | | | | 46 | | | | | | | | |
Share-based compensation expense | | 2,825 | | | | | | | | | | 2,825 | | | | | | | | |
Net income (loss) | | (5,074) | | | | | | | | | | | | | (5,074) | | | | | |
Foreign currency translation adjustment | | 0 | | | | | | | | | | | | | | | | | | |
Ending balance (in shares) at Sep. 30, 2021 | | | | | | | 63,001,701 | | | | | | | | | | | | | |
Ending balance at Sep. 30, 2021 | | $ (48,705) | | | | | | [1] | | | | 23,494 | | | (72,199) | | | 0 | 0 | |
Beginning balance (in shares) at Dec. 31, 2021 | | 73,914,149 | 42,133,496 | 412,623 | 23,668,198 | 50,245,951 | | | | | | | | | | | | | | |
Beginning balance at Dec. 31, 2021 | | $ 246,056 | $ 150,553 | $ 1,640 | $ 246,056 | | | | | | | | | | | | | | | |
Increase (Decrease) in Temporary Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Conversion of preferred stock to common stock (in shares) | | (73,914,149) | | | | | | | | | | | | | | | | | | |
Conversion of preferred stock to common stock | | $ (246,056) | | | | | | | | | | | | | | | | | | |
Ending balance (in shares) at Mar. 31, 2022 | | 0 | | | | | | | | | | | | | | | | | | |
Ending balance at Mar. 31, 2022 | | $ 0 | | | | | | | | | | | | | | | | | | |
Beginning balance (in shares) at Dec. 31, 2021 | | | | | | | 63,090,701 | | 20,269,864 | | 43,031,139 | | | | | | | | | |
Beginning balance at Dec. 31, 2021 | | (52,640) | | | $ (52,640) | | $ 5 | | | [1] | $ 5 | 25,914 | 25,919 | (5) | (78,559) | (78,559) | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Pre-close exercise of vested options (in shares) | | | | | | | 190,505 | | | | | | | | | | | | | |
Pre-close issuance of common stock upon exercise of vested options | | 102 | | | | | | | | | | 102 | | | | | | | | |
Pre-close exercise of unvested options (in shares) | | | | | | | 4,472 | | | | | | | | | | | | | |
Pre-close issuance common stock for services (in shares) | | | | | | | 62,952 | | | | | | | | | | | | | |
Pre-close issuance of common stock for services | | 621 | | | | | | | | | | 600 | | | | | | | | |
Conversion of preferred stock to common stock (in shares) | | | | | | | 73,914,149 | | | | | | | | | | | | | |
Conversion of preferred stock to common stock | | 246,056 | | | | | $ 7 | | | | | 246,049 | | | | | | | | |
Conversion of May 2020 and October 2020 preferred stock warrants of Legacy Forge to common stock warrants | | 2,949 | | | | | | | | | | 2,949 | | | | | | | | |
Exchange and settlement of common stock | | 4,207 | | | | | $ 2 | | | | | 4,205 | | | | | | | | |
Issuance of common stock upon Merger (net of redemptions), including PIPE and A&R FPA investors, net of transaction costs (in shares) | | | | | | | 31,961,047 | | | | | | | | | | | | | |
Issuance of common stock upon Merger (net of redemptions), including PIPE and A&R FPA investors, net of transaction costs | | 140,811 | | | | | $ 3 | | | | | 140,808 | | | | | | | | |
Vesting of early exercised stock options and restricted stock awards | | 409 | | | | | | | | | | 409 | | | | | | | | |
Share-based compensation expense | | 7,948 | | | | | | | | | | 7,948 | | | | | | | | |
Net income (loss) | | (64,424) | | | | | | | | | | | | | (64,424) | | | | | |
Ending balance (in shares) at Mar. 31, 2022 | | | | | | | 169,223,826 | | | | | | | | | | | | | |
Ending balance at Mar. 31, 2022 | | $ 286,039 | | | | | $ 17 | | | | | 429,005 | | | (142,983) | | | 0 | 0 | |
Beginning balance (in shares) at Dec. 31, 2021 | | 73,914,149 | 42,133,496 | 412,623 | 23,668,198 | 50,245,951 | | | | | | | | | | | | | | |
Beginning balance at Dec. 31, 2021 | | $ 246,056 | $ 150,553 | $ 1,640 | $ 246,056 | | | | | | | | | | | | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | 0 | | | | | | | | | | | | | | | | | | |
Ending balance at Sep. 30, 2022 | | $ 0 | | | | | | | | | | | | | | | | | | |
Beginning balance (in shares) at Dec. 31, 2021 | | | | | | | 63,090,701 | | 20,269,864 | | 43,031,139 | | | | | | | | | |
Beginning balance at Dec. 31, 2021 | | $ (52,640) | | | $ (52,640) | | $ 5 | | | [1] | $ 5 | 25,914 | $ 25,919 | $ (5) | (78,559) | $ (78,559) | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Issuance of Class AA common stock upon exercise of vested stock options, including stock options exercised via promissory notes (in shares) | | 1,042,214 | | | | | | | | | | | | | | | | | | |
Issuance of common stock upon exercise of public warrants (in shares) | | 1,994,790 | | | | | | | | | | | | | | | | | | |
Net income (loss) | | $ (85,741) | | | | | | | | | | | | | | | | | | |
Foreign currency translation adjustment | | (159) | | | | | | | | | | | | | | | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | | | | | | 172,442,676 | | | | | | | | | | | | | |
Ending balance at Sep. 30, 2022 | | $ 337,809 | | | | | $ 18 | | | | | 496,592 | | | (164,300) | | | (95) | 5,594 | |
Beginning balance (in shares) at Mar. 31, 2022 | | 0 | | | | | | | | | | | | | | | | | | |
Beginning balance at Mar. 31, 2022 | | $ 0 | | | | | | | | | | | | | | | | | | |
Ending balance (in shares) at Jun. 30, 2022 | | 0 | | | | | | | | | | | | | | | | | | |
Ending balance at Jun. 30, 2022 | | $ 0 | | | | | | | | | | | | | | | | | | |
Beginning balance (in shares) at Mar. 31, 2022 | | | | | | | 169,223,826 | | | | | | | | | | | | | |
Beginning balance at Mar. 31, 2022 | | 286,039 | | | | | $ 17 | | | | | 429,005 | | | (142,983) | | | 0 | 0 | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Pre-close exercise of vested options (in shares) | | | | | | | 146,232 | | | | | | | | | | | | | |
Pre-close issuance of common stock upon exercise of vested options | | 401 | | | | | | [1] | | | | 401 | | | | | | | | |
Stock Issued During Period, Shares, Acquisitions | [2] | | | | | | 210,302 | | | | | | | | | | | | | |
Issuance of common stock upon exercise of public warrants (in shares) | | | | | | | 1,994,022 | | | | | | | | | | | | | |
Issuance of common stock upon exercise of Public Warrants | | 23,629 | | | | | | [1] | | | | 23,629 | | | | | | | | |
Vesting of early exercised stock options and restricted stock awards | | 638 | | | | | | | | | | 638 | | | | | | | | |
Share-based compensation expense | | 10,903 | | | | | | | | | | 10,903 | | | | | | | | |
Net income (loss) | | (5,119) | | | | | | | | | | | | | (5,119) | | | | | |
Ending balance (in shares) at Jun. 30, 2022 | | | | | | | 171,364,080 | | | | | | | | | | | | | |
Ending balance at Jun. 30, 2022 | | $ 316,491 | | | | | $ 17 | | | | | 464,576 | | | (148,102) | | | 0 | 0 | |
Ending balance (in shares) at Sep. 30, 2022 | | 0 | | | | | | | | | | | | | | | | | | |
Ending balance at Sep. 30, 2022 | | $ 0 | | | | | | | | | | | | | | | | | | |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | | | | | | | | | | | | | | | | | | | | |
Pre-close exercise of vested options (in shares) | | | | | | | 622,929 | | | | | | | | | | | | | |
Pre-close issuance of common stock upon exercise of vested options | | 365 | | | | | | [1] | | | | 364 | | | | | | | | |
Pre-close exercise of unvested options (in shares) | | | | | | | 78,076 | | | | | | | | | | | | | |
Issuance of common stock upon exercise of Junior Preferred Stock Warrants (in shares) | | | | | | | 123,379 | | | | | | | | | | | | | |
Issuance of common stock upon exercise of Junior Preferred Stock Warrants | | 653 | | | | | | [1] | | | | 653 | | | | | | | | |
Issuance of common stock upon Merger | [1] | | | | | | | | | | | | | | | | | | | |
Formation of Forge Europe | | 9,488 | | | | | | | | | | 3,830 | | | | | | | 5,658 | |
Issuance of Class AA common stock upon exercise of vested stock options, including stock options exercised via promissory notes | | $ 193 | | | | | | | | | | 193 | | | | | | | | |
Issuance of common stock upon exercise of public warrants (in shares) | | 768 | | | | | 768 | | | | | | | | | | | | | |
Issuance of common stock upon exercise of Public Warrants | | $ 9 | | | | | | [1] | | | | 9 | | | | | | | | |
Issuance of common stock upon release of restricted stock units (in shares) | | 43,142 | | | | | | | | | | | | | | | | | | |
Issuance of common stock upon release of restricted stock units | [1] | | | | | | | | | | | | | | | | | | | |
Share-based compensation expense | | $ 26,967 | | | | | | | | | | 26,967 | | | | | | | | |
Net income (loss) | | (16,198) | | | | | | | | | | | | | (16,198) | | | | | [1] |
Foreign currency translation adjustment | | (159) | | | | | | | | | | | | | | | | (95) | (64) | |
Ending balance (in shares) at Sep. 30, 2022 | | | | | | | 172,442,676 | | | | | | | | | | | | | |
Ending balance at Sep. 30, 2022 | | $ 337,809 | | | | | $ 18 | | | | | $ 496,592 | | | $ (164,300) | | | $ (95) | $ 5,594 | |
| |
[1]amount less than 1[2]This amount represents shares that were not issued upon the closing of the Merger (see Note 3) as a result of a shareholder’s demand for appraisal rights. These shares were issued to the shareholder during the three months ended September 30, 2022 after the statutory period to perfect such rights lapsed. | |